Syros Pharmaceuticals Inc (SYRS)
5.435
-0.04
(-0.82%)
USD |
NASDAQ |
May 17, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Price: 5.435 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 5.36 | 5.52 | 5.29 | 5.45 | 163176.0 |
May 16, 2024 | 5.54 | 5.605 | 5.35 | 5.48 | 41273.00 |
May 15, 2024 | 5.49 | 5.86 | 5.36 | 5.51 | 169257.0 |
May 14, 2024 | 5.12 | 5.59 | 5.12 | 5.43 | 187271.0 |
May 13, 2024 | 4.98 | 5.16 | 4.940 | 5.06 | 91760.00 |
May 10, 2024 | 5.02 | 5.10 | 4.90 | 4.97 | 139504.0 |
May 09, 2024 | 5.00 | 5.32 | 5.00 | 5.01 | 88048.00 |
May 08, 2024 | 5.15 | 5.15 | 4.90 | 5.00 | 75489.00 |
May 07, 2024 | 5.06 | 5.32 | 5.06 | 5.15 | 105559.0 |
May 06, 2024 | 5.17 | 5.21 | 5.07 | 5.08 | 37571.00 |
May 03, 2024 | 5.15 | 5.34 | 5.05 | 5.13 | 95324.00 |
May 02, 2024 | 5.53 | 5.64 | 5.185 | 5.20 | 301219.0 |
May 01, 2024 | 5.29 | 5.650 | 5.28 | 5.44 | 199560.0 |
Apr 30, 2024 | 5.29 | 5.426 | 5.227 | 5.40 | 94794.00 |
Apr 29, 2024 | 5.08 | 5.47 | 5.045 | 5.38 | 113794.0 |
Apr 26, 2024 | 5.03 | 5.120 | 4.99 | 5.04 | 44534.00 |
Apr 25, 2024 | 4.94 | 5.15 | 4.92 | 5.10 | 128577.0 |
Apr 24, 2024 | 5.20 | 5.20 | 5.00 | 5.07 | 89636.00 |
Apr 23, 2024 | 4.98 | 5.32 | 4.98 | 5.14 | 172679.0 |
Apr 22, 2024 | 4.57 | 5.03 | 4.57 | 4.99 | 151987.0 |
Apr 19, 2024 | 4.67 | 4.72 | 4.40 | 4.54 | 262916.0 |
Apr 18, 2024 | 5.04 | 5.06 | 4.72 | 4.72 | 119453.0 |
Apr 17, 2024 | 5.55 | 5.67 | 5.09 | 5.11 | 126079.0 |
Apr 16, 2024 | 5.27 | 5.76 | 5.18 | 5.56 | 287406.0 |
Apr 15, 2024 | 5.34 | 5.63 | 5.24 | 5.35 | 148071.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.13
Minimum
Oct 18 2023
149.50
Maximum
Jan 19 2021
43.34
Average
41.30
Median
Oct 29 2021
Price Benchmarks
PAVmed Inc | 1.79 |
Moderna Inc | 132.89 |
Altimmune Inc | 8.01 |
iBio Inc | 1.98 |
Lixte Biotechnology Holdings Inc | 2.460 |
Price Related Metrics
PS Ratio | 17.07 |
Price to Book Value | 9.674 |
Earnings Yield | -92.66% |
Market Cap | 145.67M |